Adequate tacrolimus concentration for myasthenia gravis treatment.

about

Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis.

P2860

Q50047508-304569C1-2716-48FA-85AD-F4B8886ED7F3

P2860

Adequate tacrolimus concentration for myasthenia gravis treatment.

Item

http://www.wikidata.org/entity/Q51182017

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Adequate tacrolimus concentration for myasthenia gravis treatment.

@en

Adequate tacrolimus concentration for myasthenia gravis treatment.

@nl

type

Item

label

Adequate tacrolimus concentration for myasthenia gravis treatment.

@en

Adequate tacrolimus concentration for myasthenia gravis treatment.

@nl

prefLabel

Adequate tacrolimus concentration for myasthenia gravis treatment.

@en

Adequate tacrolimus concentration for myasthenia gravis treatment.

@nl

P1476

Adequate tacrolimus concentration for myasthenia gravis treatment.

@en

P2093

A Uzawa

http://www.w3.org/2001/XMLSchema#string

F Oda

http://www.w3.org/2001/XMLSchema#string

K Himuro

http://www.w3.org/2001/XMLSchema#string

N Kawaguchi

http://www.w3.org/2001/XMLSchema#string

S Kuwabara

http://www.w3.org/2001/XMLSchema#string

T Kanai

http://www.w3.org/2001/XMLSchema#string

Y Ozawa

http://www.w3.org/2001/XMLSchema#string

P2860

Myasthenia gravis

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.

Long-term treatment of generalised myasthenia gravis with FK506 (tacrolimus).

Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study

A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.

Synergistic Effects of Calcineurin Inhibitors and Steroids on Steroid Sensitivity of Peripheral Blood Mononuclear Cells.

Myasthenia gravis: subgroup classification and therapeutic strategies.

Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanes

Clinical study of FK506 in patients with myasthenia gravis.

Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study.

P304

270-275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ENE.13189

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28102047

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis

Adequate tacrolimus concentration for myasthenia gravis treatment.

about

P2860

P2860

Adequate tacrolimus concentration for myasthenia gravis treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921